Mechanisms that have been proposed to explain the pathophysiology of CMT2A associated with MFN2 dysfunctions include a defect in mitochondrial fusion, leading to a loss of mtDNA, and impairment in oxidative phosphorylation and cell bioenergetics [45]. This evidence concerns the gene MFN2 and Charcot-Marie-Tooth disease type 2A1.